Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
CALYPTE BIOMEDICAL CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
CALYPTE BIOMEDICAL CORPListing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CALYPTE BIOMEDICAL CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
CALYPTE BIOMEDICAL CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
CALYPTE BIOMEDICAL CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
CALYPTE BIOMEDICAL CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
CALYPTE BIOMEDICAL CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
CALYPTE BIOMEDICAL CORPListing unverified | Buy | $2.5M | conv 58First in 12mo | SEC | |
CALYPTE BIOMEDICAL CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
CALYPTE BIOMEDICAL CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
CALYPTE BIOMEDICAL CORPListing unverified | Buy | $3M | conv 33First in 12mo | SEC | |
CALYPTE BIOMEDICAL CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |